CA Patent

CA2082279C — Cellulase preparation comprising an endoglucanase enzyme

Assigned to Novozymes AS · Expires 2007-09-04 · 19y expired

What this patent protects

A cellulase preparation consisting essentially of a homogeneous endoglucanase component which is immunoreactive with an antibody raised against a highly purified -43kD endoglucanase derived from Humicola insoleris, DSM 1800, or which is homogeneous to said -43kD endoglucanase, ma…

USPTO Abstract

A cellulase preparation consisting essentially of a homogeneous endoglucanase component which is immunoreactive with an antibody raised against a highly purified -43kD endoglucanase derived from Humicola insoleris, DSM 1800, or which is homogeneous to said -43kD endoglucanase, may be employed in the treatment cellulose-containing fabrics for harshness reduc-tion or colour clarification or to provide a localized variation in the colour of such fabrics, or it may be employed in the treatment of paper pulp.

Drugs covered by this patent

Patent Metadata

Patent number
CA2082279C
Jurisdiction
CA
Classification
—
Expires
2007-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Novozymes AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.